arrow
Q

Qianyu Guo

shanxi bethune hospital and shanxi academy of medical sciences
H指数:19
被引数:1,121

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Unexplored limitations in a randomized trial that examines efficacy and safety of upadacitinib or elsubrutinib alone or in combination for patients with systemic lupus erythematosus: comment on the article by Merrill et al

系统性红斑狼疮患者使用乌帕替尼或艾拉鲁替尼单药或联合治疗的疗效与安全性随机试验中未被探索的局限性:对Merrill等人文章的评论

2025-01-270
PRE
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses (vol 131, e140752, 2021)
2024-05-010
OAAI
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma (vol 127, pg 4179, 2017)
2024-04-151
OAAI
MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ (vol 19, pg, 1646, 2019)
2024-04-150
OA